Key Highlights
- Remote patient monitoring (RPM) involves the utilization of digital technologies and services to oversee, analyze, and capture patients' health data, which is subsequently transmitted to healthcare professionals for thorough assessment. Market scope excludes glucose monitoring devices and neurological monitors.
- The French remote patient monitoring devices market recorded revenues of $98.4 million in 2024, representing a compound annual growth rate (CAGR) of 4.5% between 2019 and 2024.
- The implantable remote patient monitoring devices segment accounted for the market's largest proportion in 2024, with total revenues of $72 million, equivalent to 73.1% of the market's overall value.
- France has introduced several significant government initiatives to advance remote patient monitoring (RPM) as part of its broader digital health strategy.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the remote patient monitoring devices market in France
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the remote patient monitoring devices market in France
- Leading company profiles reveal details of key remote patient monitoring devices market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the France remote patient monitoring devices market with five year forecasts
Reasons to Buy
- What was the size of the France remote patient monitoring devices market by value in 2024?
- What will be the size of the France remote patient monitoring devices market in 2029?
- What factors are affecting the strength of competition in the France remote patient monitoring devices market?
- How has the market performed over the last five years?
- What are the main segments that make up France's remote patient monitoring devices market?
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biotronik SE & Co KG
- Koninklijke Philips NV
- Robert Bosch Healthcare Systems Inc